Medicine details

Image Co-Diovan
Name Co-Diovan 160/12.5
Dosage Tablet
Generic Name Hydrochlorothiazide + Valsartan
Classes Cardiovascular Agent
Antihypertensive
Antihypertensive Combination
Diseases Cardiovascular Disease
Hypertension (High Blood Pressure)
Company Novartis (Bangladesh) Ltd.

Drug Package Details

Strength 12.5 mg + 160 mg
Storage Condition
Origin Country Bangladesh
Commercial Pack 28
Price per pack 1,853.60
Cost per pack 1,631.17
Package unit 14 tabs strip
Price per unit 66.20
Cost per unit 58.26
Discount 0
Coupon
Remarks

Hydrochlorothiazide + Valsartan

Hydrochlorothiazide + Valsartan is a combination of valsartan, an orally active, AT1 receptor subtype specific angiotensin II receptor blocker (ARB), and hydrochlorothiazide, a diuretic.

 

This combination is used to treat Hypertension.

  • Hydrochlorothiazide + Valsartan is available as tablets. 
  • Hydrochlorothiazide + Valsartan 160/12.5 mg once day is the usual beginning dose. After 1 to 2 weeks of therapy, the dosage can be increased to a maximum of one 320/25 tablet once day as needed to regulate blood pressure. After a dosage modification, the maximum antihypertensive effects are achieved in 2 to 4 weeks.

The side effects associated with the medication are as follows-

  • headache
  • dizziness
  • Pharyngitis
  • Hypotension
  • Tinnitus
  • Dyspepesia
  • Asthenia
  • During the second and third trimesters of pregnancy, medications that act on the renin-angiotensin system impair fetal renal function and increase fetal and newborn morbidity and death.
  • In controlled trials, patients with uncomplicated hypertension treated with Hydrochlorothiazide + Valsartan experienced a very little (0.7 percent) drop in blood pressure. Symptomatic hypotension can occur in patients with an active renin-angiotensin system, such as volume- and/or salt-depleted patients on high doses of diuretics.

Contraindication

  •  Contraindicated to the patients who are sensitive to hydrochlorothiazide or to other sulfonamide-derived drugs, such as-
  • Contraindicated to the patients who are sensitive to valsartan or other ARBs, such as-
  • Concomitant use of Hydrochlorothiazide + Valsartan with aliskiren containing products in patients with diabetes mellitus or renal impairment.
  • Hydrochlorothiazide + Valsartan is contraindicated in pregnancy.
  • Hydrochlorothiazide + Valsartan is contraindicated in patients with severe kidney problems (GFR 30 mL/min) and anuria due to the hydrochlorothiazide component.
  • Hydrochlorothiazide + Valsartan is contraindicated in patients with significant hepatic problems or biliary cirrhosis and cholestasis due to the valsartan component.